'Adjuvant trastuzumab' presentation slideshows

ARCC Canadian Centre for Applied Research in Cancer Control

280 views • 19 slides

Thomas C. Rindflesch, Ph.D., FACMI National Library of Medicine

Effectively Exploiting Big Data with Semantics: A Pilot Project. Thomas C. Rindflesch, Ph.D., FACMI National Library of Medicine. Disclaimer.

326 views • 18 slides

Current Patterns of Care in Breast Cancer: Use of Adjuvant Trastuzumab

423 views • 14 slides

Goldhirsch A et al. Proc SABCS 2012;Abstract S5-2.

HERA TRIAL: 2 Years versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up. Goldhirsch A et al. Proc SABCS 2012;Abstract S5-2. Background.

265 views • 10 slides

Pivot X et al. Proc SABCS 2012 ; Abstract S5-3.

PHARE Trial Results of Subset Analysis Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer. Pivot X et al. Proc SABCS 2012 ; Abstract S5-3. Background.

229 views • 7 slides